Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Clinical Study on Carbohydrate Control, Weight Loss Published in Scientific Journal
- Clinical Study on Carbohydrate Control, Weight Loss Published in Scientific Journal
- New Studies Show Curves(TM) Program Raises Metabolic Rate in Overweight and Sedentary Women
- New Studies Show Curves(TM) Program Raises Metabolic Rate in Overweight and Sedentary Women
- New Studies Show Curves(TM) Program Raises Metabolic Rate in Overweight and Sedentary Women
- Overweight/Obese Children Lose Weight, Improve Lipid Levels in Pritikin Family Program
Center presents data demonstrating results in reducing cholesterol, triglyceride levels and weight.
- Overweight/Obese Children Lose Weight, Improve Lipid Levels in Pritikin Family Program
Center presents data demonstrating results in reducing cholesterol, triglyceride levels and weight.
- Overweight/Obese Children Lose Weight, Improve Lipid Levels in Pritikin Family Program
Center presents data demonstrating results in reducing cholesterol, triglyceride levels and weight.
- Recent Study Reinforces the Benefits of Omega-3 for Weight Control
Article published in Lipids 2004 presents effects on weight reduction in obesity prone animals using different omega-3 concentrates containing EPA or DHA.
- Recent Study Reinforces the Benefits of Omega-3 for Weight Control
Article published in Lipids 2004 presents effects on weight reduction in obesity prone animals using different omega-3 concentrates containing EPA or DHA.
- Recent Study Reinforces the Benefits of Omega-3 for Weight Control
Article published in Lipids 2004 presents effects on weight reduction in obesity prone animals using different omega-3 concentrates containing EPA or DHA.
- Recent Study Reinforces the Benefits of Omega-3 for Weight Control
Article published in Lipids 2004 presents effects on weight reduction in obesity prone animals using different omega-3 concentrates containing EPA or DHA.
- Recent Study Reinforces the Benefits of Omega-3 for Weight Control
Article published in Lipids 2004 presents effects on weight reduction in obesity prone animals using different omega-3 concentrates containing EPA or DHA.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- New Chromium Supplementation Clinical Trial Initiated - First to Study Effects in Overweight Children with Type 1 Diabetes
Double-blind, randomized, placebo-controlled clinical trial to study the effects of chromium picolinate supplementation in overweight pediatric patients with poorly-controlled type 1 diabetes to be initiated at Childrens Hospital Los Angeles.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection
Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Research Shows Natural Resistant Starch Increases Metabolic Biomarkers for Satiety and Reduces Abdominal Fat
New research presented at the 2006 Annual Meeting of NAASO, The Obesity Society, yesterday showed that fermentation of natural resistant starch derived from corn is an important and previously under-estimated mechanism in weight management with more impact on cellular metabolism and fat deposition than the other mechanisms of dietary fiber.
- New Research Shows Natural Resistant Starch Increases Metabolic Biomarkers for Satiety and Reduces Abdominal Fat
New research presented at the 2006 Annual Meeting of NAASO, The Obesity Society, yesterday showed that fermentation of natural resistant starch derived from corn is an important and previously under-estimated mechanism in weight management with more impact on cellular metabolism and fat deposition than the other mechanisms of dietary fiber.
- New Research Shows Natural Resistant Starch Increases Metabolic Biomarkers for Satiety and Reduces Abdominal Fat
New research presented at the 2006 Annual Meeting of NAASO, The Obesity Society, yesterday showed that fermentation of natural resistant starch derived from corn is an important and previously under-estimated mechanism in weight management with more impact on cellular metabolism and fat deposition than the other mechanisms of dietary fiber.
- Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat
Results of a new mouse study, published in Physiology Genomics, indicate that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development.
- Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat
Results of a new mouse study, published in Physiology Genomics, indicate that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development.
- Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat
Results of a new mouse study, published in Physiology Genomics, indicate that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
|
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.
A third of global deaths happen in children younger than 5 years; most occur in the neonatal period – the first four weeks of life. Low birthweight (less than 2500 g) underlies many of these deaths. Around 25 million low-birthweight infants are born every year. Maternal nutritional status is closely linked with foetal weight. Increases in macronutrient consumption during pregnancy can lead to increased birthweight.
David Osrin (Institute of Child Health, UK) and colleagues did a trial to test whether multiple micronutrient supplementation at one recommended daily allowance would increase birthweight and help prolong pregnancy to full term. 1200 women from Nepal, who had reached up to 20 weeks of pregnancy, were recruited onto the trial between August 2002 and October 2003. Women were randomly assigned to receive either a supplement containing 10 vitamins (vitamin A, E, D, B1, B2, B6, B12, C, niacin, folic acid) and five minerals (iron, zinc, copper, selenium, iodine) or the nationally advised tablets containing iron and folic acid once daily for an average of 160 days. Birthweight data for 1052 babies was available in the analysis. The average birthweight was 2733 g in the control group and 2810 g in the intervention group, representing an average difference of 77 g and reduction in the prevalence of low birthweight by 25%. The length of pregnancy was 1·5 days longer in the intervention group than in the control group but that result was not significant. The difference in the mean birthweight was more marked in female infants (108 g compared with 44 g in males) and in infants of mothers whose body mass index was 18·5kg/m2 or more (83 g compared with 54g in those with a body mass index of less than 18.5 kg/m2).
Dr Osrin concludes: “Our tentative finding of a differential effect of the supplement is interesting. The effect of multiple micronutrients on foetal weight seems to have been enhanced in female infants, in births of higher order, and in babies of women with greater body-mass index. The public-health implications of our findings await confirmation by the results of other studies currently underway.”
Contact Dr David Osrin, International Perinatal Care Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK. T) 0207 905 2261 EMBARGO: 10:00H ET Thursday March 3, 2005 |